# A Randomized Controlled Phase II Trial of STIMULAN VG vs Standard of Care (SoC) for the Treatment of Osteomyelitis Associated With Stage IV Pressure Ulcers.

> **NCT06283979** · PHASE2 · RECRUITING · sponsor: **Biocomposites Ltd** · enrollment: 60 (estimated)

## Conditions studied

- Pressure Ulcer, Stage IV
- Osteomyelitis

## Interventions

- **COMBINATION_PRODUCT:** STIMULAN VG
- **PROCEDURE:** Standard of Care

## Key facts

- **NCT ID:** NCT06283979
- **Lead sponsor:** Biocomposites Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-15
- **Primary completion:** 2026-12-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06283979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06283979, "A Randomized Controlled Phase II Trial of STIMULAN VG vs Standard of Care (SoC) for the Treatment of Osteomyelitis Associated With Stage IV Pressure Ulcers.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06283979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*